Citizens National Bank Trust Department Has $10.40 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Citizens National Bank Trust Department decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 17,789 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. UnitedHealth Group comprises approximately 2.2% of Citizens National Bank Trust Department’s portfolio, making the stock its 8th biggest holding. Citizens National Bank Trust Department’s holdings in UnitedHealth Group were worth $10,401,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Delta Financial Group Inc. raised its stake in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the last quarter. Signature Resources Capital Management LLC boosted its position in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the last quarter. Saxony Capital Management LLC raised its position in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the last quarter. GoalVest Advisory LLC increased its position in UnitedHealth Group by 0.6% in the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC lifted its position in UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of UNH opened at $567.56 on Monday. The company has a 50 day moving average of $581.96 and a 200-day moving average of $542.45. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $524.10 billion, a P/E ratio of 36.97, a P/E/G ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the business posted $6.56 EPS. The company’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.